In Re: Xarelto (Rivaroxaban) (310) Patent Litigation

1:2021-md-03017
ANDA
Cause of ActionLogin To View
Appeal NumberLogin To View
StatusLogin To View
OutcomeSubscription-Only
Patent0
-
Filing DateDec 10, 2021
Termination DateLogin To View
CourtLogin To View
JudgesLogin To View
Case LengthLogin To View
Technology Center-
Plaintiff
3
Bayer Corporation
Johnson & Johnson
Defendant
3
Micro Labs Ltd
Sciegen Pharmaceuticals Inc.
ANDA report image

Empower your practice with Patexia ANDA IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a ANDA Attorney & Experts?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.